The 4 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 4.75. The median estimate represents a +70.81% increase from the last price of 3.22.
The current consensus among 5 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.53
Reporting Date Feb 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.